Annerén G., Enberg G., and Sara V. R., “The Presence of Normal Levels of Serum Immunoreactive Insulin-like Growth Factor 2 (IGF-2) in Patients with Down’s Syndrome”, ujms, vol. 89, no. 3, pp. 274-278, Sep. 1984.